These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17928410)

  • 1. Nitric oxide deficiency in chronic kidney disease.
    Baylis C
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F1-9. PubMed ID: 17928410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
    Baylis C
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):209-20. PubMed ID: 16932427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase derangements and hypertension in kidney disease.
    Baylis C
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):1-6. PubMed ID: 22048724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease.
    Alpoim PN; Sousa LP; Mota AP; Rios DR; Dusse LM
    Clin Chim Acta; 2015 Feb; 440():36-9. PubMed ID: 25444745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
    Ueda S; Yamagishi SI; Matsumoto Y; Fukami K; Okuda S
    Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis.
    Wagner L; Riggleman A; Erdely A; Couser W; Baylis C
    Kidney Int; 2002 Aug; 62(2):532-6. PubMed ID: 12110014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase inhibitors and cerebral vasospasm.
    Jung CS
    Acta Neurochir Suppl; 2011; 110(Pt 1):87-91. PubMed ID: 21116921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Asymmetric dimethylarginine: metabolism, arginine paradox, pathophysiology].
    Gilinskiĭ MA
    Usp Fiziol Nauk; 2007; 38(3):21-39. PubMed ID: 17977229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction.
    Masuda H
    Int J Urol; 2008 Feb; 15(2):128-34. PubMed ID: 18269446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reduced nitric oxide bioavailability in chronic renal failure: a new factor of progression?].
    Bonomini M; Sirolli V; Di Pietro N; Pandolfi A
    G Ital Nefrol; 2008; 25(3):306-16. PubMed ID: 18473302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelium as a target in renal diseases.
    Zoccali C
    J Nephrol; 2007; 20 Suppl 12():S39-44. PubMed ID: 18050141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
    Zoccali C; Kielstein JT
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):314-20. PubMed ID: 16609301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition.
    Zsuga J; Gesztelyi R; Török J; Kéki S; Bereczki D
    Med Hypotheses; 2005; 65(6):1091-8. PubMed ID: 16125868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat.
    Momohara Y; Sakamoto S; Obayashi S; Aso T; Goto M; Azuma H
    Mol Hum Reprod; 2004 Jul; 10(7):505-12. PubMed ID: 15155819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.
    Pluta RM
    Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A; Zhao Y; Warren JS
    Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal changes of renal neuronal nitric oxide synthase-α and -β associated with renal progression in a neonatal 5/6 nephrectomized rat model.
    Tain YL; Ghosh S; Krieg RJ; Baylis C
    Pediatr Neonatol; 2011 Apr; 52(2):66-72. PubMed ID: 21524625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals.
    Carlström M; Brown RD; Edlund J; Sällström J; Larsson E; Teerlink T; Palm F; Wåhlin N; Persson AE
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F362-70. PubMed ID: 18032548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.